REVUE NEUROLOGIQUE

REVUE NEUROLOGIQUE(英文缩写 REV NEUROL-FRANCE),ISSN 0035-3787,eISSN 2213-0004 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

发文量统计区间：2025-09-21 至 2026-09-21，按本站收录文献的发表日期统计。

指标来源：jcr_cas_ifqb

历年影响因子趋势

REVUE NEUROLOGIQUE 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

1. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   1. Cranial nerve III palsy with contralateral peripheral upper-limb involvement in Lyme neuroborreliosis.

   PMID:

   42754437

   作者:

   T Sinha, H Khuram, N S Streicher

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.08.001

   日期:

   2026-09-17

   查看详情PubMed 原文记录
2. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   2. Access to hospital-based rehabilitation for people with multiple sclerosis in France: A nationwide study (2017-2023).

   PMID:

   42705931

   作者:

   M Mainguy, C Massot, P Gallien, V Reynaud, E Leray, C Donzé

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.07.007

   日期:

   2026-09-07

   Multiple sclerosis (MS) is frequently associated with progressive motor and functional impairment that requires multidisciplinary rehabilitation. In France, coordinated inpatient and outpatient rehabilitation is delivered at hospital-based facilities. However, national population-based data on the a…

   查看详情PubMed 原文记录
3. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   3. Effect of levodopa-carbidopa intestinal gel infusion on objective measures of daytime sleepiness and nocturnal sleep in Parkinson's disease.

   PMID:

   42692964

   作者:

   M Bucy, N Carpentier, G Clement, S Richard, S Frismand-Kryloff, E Ruppert

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.07.002

   日期:

   2026-09-03

   Excessive daytime sleepiness and sleep disturbances are common in Parkinson's disease (PD), considerably affecting the quality of life of patients and caregivers. Antiparkinsonian medications further complicate sleep-wake management. Advanced PD with motor fluctuations often requires continuous dopa…

   查看详情PubMed 原文记录
4. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   4. Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry.

   PMID:

   42457526

   作者:

   S Ferrao-Malheiro, R Fabre, M Lanteri-Minet

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.05.006

   日期:

   2026-09-01

   Candesartan is recommended for migraine prevention, but real-world data on effectiveness, persistence of response, and titration tolerability across episodic migraine (EM) and chronic migraine (CM) and treatment lines are limited. We analyzed consecutive adults starting candesartan for migraine prev…

   查看详情PubMed 原文记录
5. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   5. Beyond migraine: A narrative review of photophobia's clinical spectrum.

   5. 偏头痛之外：对畏光症临床谱的叙述性回顾

   PMID:

   42425853

   作者:

   D Doukhi, C Vignal, J Mawet

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.06.002

   日期:

   2026-09-01

   Photophobia is a frequent and often disabling symptom encountered in a wide range of neurological and ophthalmological conditions. Particularly prevalent in migraine, but also observed in common eye diseases, photophobia reflects complex interactions between visual and nociceptive pathways. This rev…

   查看详情PubMed 原文记录
6. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   6. Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

   PMID:

   42399152

   作者:

   R Demeret, D Vieles Marais, E Treiner, B Acket, V Fabry, T Levade, L Nogueira, J-C Pages, P Cintas

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.05.005

   日期:

   2026-09-01

   Intrathecal antisense oligonucleotides (ASOs) have revolutionized the management of genetic motor neuron diseases. Nusinersen is approved for spinal muscular atrophy (SMA) caused by SMN1 mutations, and tofersen for amyotrophic lateral sclerosis (ALS) linked to SOD1 mutations. Since their approval, s…

   查看详情PubMed 原文记录
7. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   7. Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

   PMID:

   42373365

   作者:

   C Maisonnier, J-P Cottier, G Charbonnier, A Monaya, J Rhein, M Gaudron, M Haba, N Deschamps, A Nasri, B de Toffol, I L Maldonado

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.05.004

   日期:

   2026-09-01

   Stroke disproportionately affects French Guiana, which has the highest incidence and premature stroke mortality among French territories. Beyond traditional vascular risks, cerebral small vessel disease (CSVD) may explain these disparities. This study compared MRI characteristics of acute ischemic s…

   查看详情PubMed 原文记录
8. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   8. Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort study.

   PMID:

   42203566

   作者:

   C Desjardins, H de Saint Vaulry, C Rosset, Q Salardaine, J-P Brandel, G Baille

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.05.001

   日期:

   2026-09-01

   The optimal setting for initiating subcutaneous foslevodopa/foscarbidopa (CSFLI) in advanced Parkinson's disease remains debated. This study aimed to compare six-month clinical outcomes according to initiation setting. We conducted a retrospective cohort study of consecutive patients with advanced P…

   查看详情PubMed 原文记录
9. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

   9. Passive digital monitoring via mobile apps and wearables in multiple sclerosis: A systematic review.

   9. 通过移动应用程序和可穿戴设备对多发性硬化症进行被动数字监测：系统综述

   PMID:

   42674905

   作者:

   Paolo De Blasiis, Annunziata Attena, Allegra Fullin, Ciro Ivan De Girolamo, Antonio Carotenuto, Elisabetta Signoriello, Vincenzo Brescia Morra, Giacomo Lus, Francesco Isgrò, Nicola Moccaldi, Pasquale Arpaia

   期刊:

   Revue neurologique PubMed

   DOI:

   10.1016/j.neurol.2026.07.006

   日期:

   2026-08-31

   Effective management of multiple sclerosis requires precise monitoring to detect disease progression, yet conventional episodic assessments often fail to capture subtle functional decline. This systematic review aimed to synthesize current evidence on passive digital phenotyping via smartphones and …

   查看详情PubMed 原文记录
10. JCR分区: Q3 CAS分区: B4 影响因子: 2.7

    10. Complement inhibition as rescue therapy in life-threatening refractory chronic inflammatory demyelinating polyneuropathy.

    PMID:

    42665511

    作者:

    Audrey Cambier, Simon Jean-Marie, Karine Viala, Charline Benoit, Nicolas Weiss, Clémence Marois

    期刊:

    Revue neurologique PubMed

    DOI:

    10.1016/j.neurol.2026.07.005

    日期:

    2026-08-28

    查看详情PubMed 原文记录